|
Commission Regulation (EC) No
2237/2004 of 29 December 2004 amending Regulation (EC) No 1725/2003
adopting certain international accounting standards in accordance
with Regulation (EC) No 1606/2002 of the European Parliament and of
the Council, as regards IAS No 32 and IFRIC 1
Content |
|
- |
Settlement in the
Entity’s Own Equity Instruments (paragraph 16(b))
21. A contract is
not an equity instrument solely because it may result in the
receipt or delivery of the entity’s own equity instruments.
An entity may have a contractual right or obligation to
receive or deliver a number of its own shares or other equity
instruments that varies so that the fair value of the entity’s
own equity instruments to be received or delivered equals the
amount of the contractual right or obligation. Such a
contractual right or obligation may be for a fixed amount or
an amount that fluctuates in part or in full in response to
changes in a variable other than the market price of the
entity’s own equity instruments (eg an interest rate, a
commodity price or a financial instrument price). Two examples
are (a) a contract to deliver as many of the entity’s own
equity instruments as are equal in value to CU100 (In this
Standard, monetary amounts are denominated in ‘currency
units’ (CU).), and (b) a contract to deliver as many of the
entity’s own equity instruments as are equal in value to the
value of 100 ounces of gold. Such a contract is a financial
liability of the entity even though the entity must or can
settle it by delivering its own equity instruments. It is not
an equity instrument because the entity uses a variable number
of its own equity instruments as a means to settle the
contract. Accordingly, the contract does not evidence a
residual interest in the entity’s assets after deducting all
of its liabilities.
22. A contract that
will be settled by the entity (receiving or) delivering a
fixed number of its own equity instruments in exchange for a
fixed amount of cash or another financial asset is an equity
instrument. For example, an issued share option that gives the
counterparty a right to buy a fixed number of the entity’s
shares for a fixed price or for a fixed stated principal
amount of a bond is an equity instrument. Changes in the fair
value of a contract arising from variations in market interest
rates that do not affect the amount of cash or other financial
assets to be paid or received, or the number of equity
instruments to be received or delivered, on settlement of the
contract do not preclude the contract from being an equity
instrument. Any consideration received (such as the premium
received for a written option or warrant on the entity’s own
shares) is added directly to equity. Any consideration paid
(such as the premium paid for a purchased option) is deducted
directly from equity. Changes in the fair value of an equity
instrument are not recognised in the financial statements.
23. A contract that
contains an obligation for an entity to purchase its own
equity instruments for cash or another financial asset gives
rise to a financial liability for the present value of the
redemption amount (for example, for the present value of the
forward repurchase price, option exercise price or other
redemption amount). This is the case even if the contract
itself is an equity instrument. One example is an entity’s
obligation under a forward contract to purchase its own equity
instruments for cash. When the financial liability is
recognised initially under IAS 39, its fair value (the present
value of the redemption amount) is reclassified from equity.
Subsequently, the financial liability is measured in
accordance with IAS 39. If the contract expires without
delivery, the carrying amount of the financial liability is
reclassified to equity. An entity’s contractual obligation
to purchase its own equity instruments gives rise to a
financial liability for the present value of the redemption
amount even if the obligation to purchase is conditional on
the counterparty exercising a right to redeem (eg a written
put option that gives the counterparty the right to sell an
entity’s own equity instruments to the entity for a fixed
price).
24. A contract that
will be settled by the entity delivering or receiving a fixed
number of its own equity instruments in exchange for a
variable amount of cash or another financial asset is a
financial asset or financial liability. An example is a
contract for the entity to deliver 100 of its own equity
instruments in return for an amount of cash calculated to
equal the value of 100 ounces of gold.
Contingent
Settlement Provisions
25. A financial
instrument may require the entity to deliver cash or another
financial asset, or otherwise to settle it in such a way that
it would be a financial liability, in the event of the
occurrence or nonoccurrence of uncertain future events (or on
the outcome of uncertain circumstances) that are beyond the
control of both the issuer and the holder of the instrument,
such as a change in a stock market index, consumer price index,
interest rate or taxation requirements, or the issuer’s
future revenues, net income or debt-to-equity ratio. The
issuer of such an instrument does not have the unconditional
right to avoid delivering cash or another financial asset (or
otherwise to settle it in such a way that it would be a
financial liability). Therefore, it is a financial liability
of the issuer unless:
(a) the part of the
contingent settlement provision that could require settlement
in cash or another financial asset (or otherwise in such a way
that it would be a financial liability) is not genuine; or
(b) the issuer can
be required to settle the obligation in cash or another
financial asset (or otherwise to settle it in such a way that
it would be a financial liability) only in the event of
liquidation of the issuer.
Settlement Options
26. When a
derivative financial instrument gives one party a choice over
how it is settled (eg the issuer or the holder can
choose settlement net in cash or by exchanging
shares for cash), it is a financial asset or a
financial liability unless all of the settlement alternatives
would result in it being an equity instrument.
27. An example of a
derivative financial instrument with a settlement option that
is a financial liability is a share option that the issuer can
decide to settle net in cash or by exchanging its own shares
for cash. Similarly, some contracts to buy or sell a
non-financial item in exchange for the entity’s own equity
instruments are within the scope of this Standard because they
can be settled either by delivery of the non-financial item or
net in cash or another financial instrument (see paragraphs
8-10). Such contracts are financial assets or financial
liabilities and not equity instruments.
Compound Financial Instruments (see also paragraphs
AG30-AG35 and Illustrative Examples 9-12)
28. The issuer of a
non-derivative financial instrument shall evaluate the
terms of the financial instrument to determine whether it
contains both a liability and an equity component. Such
components shall be classified separately as financial
liabilities, financial assets or equity
instruments in accordance with paragraph 15.
29. An entity
recognises separately the components of a financial instrument
that (a) creates a financial liability of the entity and (b)
grants an option to the holder of the instrument to convert it
into an equity instrument of the entity. For example, a bond
or similar instrument convertible by the holder into a fixed
number of ordinary shares of the entity is a compound
financial instrument. From the perspective of the entity, such
an instrument comprises two components: a financial liability
(a contractual arrangement to deliver cash or another
financial asset) and an equity instrument (a call option
granting the holder the right, for a specified period of time,
to convert it into a fixed number of ordinary shares of the
entity). The economic effect of issuing such an instrument is
substantially the same as issuing simultaneously a debt
instrument with an early settlement provision and warrants to
purchase ordinary shares, or issuing a debt instrument with
detachable share purchase warrants. Accordingly, in all cases,
the entity presents the liability and equity components
separately on its balance sheet.
30. Classification
of the liability and equity components of a convertible
instrument is not revised as a result of a change in the
likelihood that a conversion option will be exercised, even
when exercise of the option may appear to have become
economically advantageous to some holders. Holders may not
always act in the way that might be expected because, for
example, the tax consequences resulting from conversion may
differ among holders. Furthermore, the likelihood of
conversion will change from time to time. The entity’s
contractual obligation to make future payments remains
outstanding until it is extinguished through conversion,
maturity of the instrument or some other transaction.
31. IAS 39 deals
with the measurement of financial assets and financial
liabilities. Equity instruments are instruments that evidence
a residual interest in the assets of an entity after deducting
all of its liabilities. Therefore, when the initial carrying
amount of a compound financial instrument is allocated to its
equity and liability components, the equity component is
assigned the residual amount after deducting from the fair
value of the instrument as a whole the amount separately
determined for the liability component. The value of any
derivative features (such as a call option) embedded in the
compound financial instrument other than the equity component
(such as an equity conversion option) is included in the
liability component. The sum of the carrying amounts assigned
to the liability and equity components on initial recognition
is always equal to the fair value that would be ascribed to
the instrument as a whole. No gain or loss arises from
initially recognising the components of the instrument
separately.
32. Under the
approach described in paragraph 31, the issuer of a bond
convertible into ordinary shares first determines the carrying
amount of the liability component by measuring the fair value
of a similar liability (including any embedded non-equity
derivative features) that does not have an associated equity
component. The carrying amount of the equity instrument
represented by the option to convert the instrument into
ordinary shares is then determined by deducting the fair value
of the financial liability from the fair value of the compound
financial instrument as a whole.
Previous |
Index |
Next
|